Chemours
458 hedge funds and large institutions have $5.6B invested in Chemours in 2017 Q1 according to their latest regulatory filings, with 92 funds opening new positions, 109 increasing their positions, 157 reducing their positions, and 41 closing their positions.
151% more call options, than puts
Call options by funds: $111M | Put options by funds: $44.3M
124% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 41
100% more funds holding in top 10
Funds holding in top 10: 6 → 12 (+6)
79% more capital invested
Capital invested by funds: $3.13B → $5.6B (+$2.47B)
10% more funds holding
Funds holding: 416 → 458 (+42)
1% more ownership
Funds ownership: 78.04% → 79.04% (+1%)
31% less repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 157
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$575M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$120M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$64.2M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$52.6M |
| 5 |
Renaissance Technologies
New York
|
+$52.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Greenlight Capital
New York
|
-$119M |
| 2 |
SC
Sessa Capital
New York
|
-$83.8M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$56.5M |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$52M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$30.3M |
CC Hedge Fund Activity: Q1 2017 in Review
458 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2017, worth a combined $5.6B — up 79% from $3.13B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new CC positions and 41 closed out — a net gain of 51 holders — while 109 added to existing stakes and 157 trimmed.
The largest buyer was BlackRock, adding an estimated $575M. The largest seller was Greenlight Capital, cutting an estimated $119M.
- 458 institutional investors held Chemours (CC) as of Q1 2017, up from 416 in Q4 2016.
- Funds reported $5.6B of Chemours stock for Q1 2017, up 79% quarter-over-quarter.
- 92 funds opened new Chemours positions in Q1 2017 and 41 closed out, a net change of +51 holders.
- The largest Chemours buyer in Q1 2017 was BlackRock, an estimated $575M added.
- The largest Chemours seller in Q1 2017 was Greenlight Capital, an estimated $119M sold.
Based on aggregated 13F filings for Q1 2017.